Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

This antibody was utilized to covalently functionalize single-wall carbon nanotubes, which enabled improved vascular inhibition ... roles in rapid tumor growth and distant metastasis, and is ...

Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice.

The FDA has granted fast track designation to emiltatug ledadotin for advanced or metastatic breast cancer treatment, as ...

The FDA also approved Qiagen's Therascreen KRAS RGQ PCR kit as a companion diagnostic to identify KRAS G12C-mutant patients.

The grant will fund the development of a novel formulation of SNX631-6, the Company's CDK8/19 Mediator kinase inhibitor and clinical candidate as a treatment for metastatic ovarian cancer (OC).

Award follows extensive pre-clinical, single agent activity data generated by Prof. Colleen Nelson's lab at QUT in 'Aggressive Variant' prostate ca ...